NO791225L - Fremgangsmaate for fremstilling av 2-aminopyrimidoner - Google Patents

Fremgangsmaate for fremstilling av 2-aminopyrimidoner

Info

Publication number
NO791225L
NO791225L NO791225A NO791225A NO791225L NO 791225 L NO791225 L NO 791225L NO 791225 A NO791225 A NO 791225A NO 791225 A NO791225 A NO 791225A NO 791225 L NO791225 L NO 791225L
Authority
NO
Norway
Prior art keywords
pyrimidone
methyl
mixture
pyridyl
pyridylmethyl
Prior art date
Application number
NO791225A
Other languages
English (en)
Norwegian (no)
Inventor
Thomas Henry Brown
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Publication of NO791225L publication Critical patent/NO791225L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
NO791225A 1978-04-11 1979-04-10 Fremgangsmaate for fremstilling av 2-aminopyrimidoner NO791225L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1404978 1978-04-11

Publications (1)

Publication Number Publication Date
NO791225L true NO791225L (no) 1979-10-12

Family

ID=10034068

Family Applications (1)

Application Number Title Priority Date Filing Date
NO791225A NO791225L (no) 1978-04-11 1979-04-10 Fremgangsmaate for fremstilling av 2-aminopyrimidoner

Country Status (31)

Country Link
US (1) US4523015A (cs)
EP (1) EP0004793B1 (cs)
JP (1) JPS54138580A (cs)
KR (1) KR820002136B1 (cs)
AT (1) AT372956B (cs)
AU (1) AU527202B2 (cs)
CA (1) CA1138453A (cs)
CS (1) CS210684B2 (cs)
CY (1) CY1194A (cs)
DD (1) DD142878A5 (cs)
DE (1) DE2961652D1 (cs)
DK (1) DK147379A (cs)
ES (1) ES479469A1 (cs)
FI (1) FI791143A7 (cs)
GR (1) GR66986B (cs)
HU (1) HU180081B (cs)
IE (1) IE48080B1 (cs)
IL (1) IL57005A (cs)
IT (1) IT1118476B (cs)
KE (1) KE3284A (cs)
MX (1) MX5898E (cs)
MY (1) MY8500703A (cs)
NO (1) NO791225L (cs)
NZ (1) NZ190122A (cs)
PH (2) PH16240A (cs)
PL (2) PL117998B1 (cs)
PT (1) PT69464A (cs)
RO (1) RO76810A (cs)
SU (2) SU944504A3 (cs)
YU (1) YU84179A (cs)
ZA (1) ZA791616B (cs)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN151188B (cs) * 1978-02-13 1983-03-05 Smith Kline French Lab
CA1140129A (en) * 1979-08-21 1983-01-25 Ronald J. King 4-pyrimidone derivatives
CA1155842A (en) * 1980-03-29 1983-10-25 Thomas H. Brown Compounds
US4352933A (en) * 1981-02-06 1982-10-05 Smithkline Beckman Corporation Chemical methods and intermediates for preparing substituted pyrimidinones
ZA823149B (en) * 1981-05-27 1983-03-30 Smithkline Beckman Corp Chemical process
PT74865B (en) * 1981-05-27 1983-12-07 Smithkline Beckman Corp Process of preparing a 2-(pyridylbutylamino)-pyrimidone and of its pharmaceutically acceptable salts
DK230482A (da) * 1981-05-30 1982-12-01 Smith Kline French Lab Pyrimidonsalt og fremstilling heraf
US4772704A (en) * 1983-09-21 1988-09-20 Bristol-Myers Company 2,5-disubstituted-4(3H)-pyrimidones having histamine H2 -receptor antagonist activity
IL75400A (en) * 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
GB8421427D0 (en) * 1984-08-23 1984-09-26 Smith Kline French Lab Chemical compounds
DE3532880A1 (de) * 1985-09-14 1987-03-26 Basf Ag 1,4-disubstituierte pyrazolderivate
JP2807577B2 (ja) * 1990-06-15 1998-10-08 エーザイ株式会社 環状アミド誘導体
CN107698501A (zh) * 2017-10-25 2018-02-16 遵义医学院 5,6‑二甲基‑2‑羟基烟酸的制备工艺
US20230349922A1 (en) 2020-08-11 2023-11-02 Université De Strasbourg H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and Cancer

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE787372A (fr) * 1971-08-09 1973-02-09 Ici Ltd 2-nitroamino-6-hydroxy-4-methylpyrimidines substituees en position 5
GB1383676A (en) * 1972-07-14 1974-02-12 Ici Ltd Process for making diethylamino pyrimidine derivatives
GB1419994A (en) * 1973-05-03 1976-01-07 Smith Kline French Lab Heterocyclicalkylaminotheterocyclic compounds methods for their preparation and compositions comprising them
US4145546A (en) * 1975-10-02 1979-03-20 Smith Kline & French Laboratories Limited 4-Pyrimidone compounds
IN146736B (cs) * 1975-10-02 1979-08-25 Smith Kline French Lab
US4154834A (en) * 1975-12-29 1979-05-15 Smith Kline & French Laboratories Limited Substituted isocytosines having histamine H2 -antagonist activity
US4216318A (en) * 1975-12-29 1980-08-05 Smith Kline & French Laboratories Limited Heterocyclic alkyl 4-pyrimidones
MW5076A1 (en) * 1975-12-29 1978-02-08 Smith Kline French Lab Pharmacologicalle active compounds
US4227000A (en) * 1978-04-11 1980-10-07 Smith Kline & French Laboratories Limited Intermediates in the process for making histamine antagonists
PT69886A (en) * 1978-07-15 1979-08-01 Smith Kline French Lab Process for preparing isoureas and isothioureas

Also Published As

Publication number Publication date
NZ190122A (en) 1982-03-09
DD142878A5 (de) 1980-07-16
EP0004793B1 (en) 1981-12-30
PH16841A (en) 1984-03-15
PL214792A1 (cs) 1980-03-24
PL117998B1 (en) 1981-09-30
AU4571479A (en) 1979-10-18
HU180081B (en) 1983-01-28
FI791143A7 (fi) 1981-01-01
DE2961652D1 (en) 1982-02-18
EP0004793A2 (en) 1979-10-17
KE3284A (en) 1983-05-13
ZA791616B (en) 1980-04-30
PT69464A (en) 1979-05-01
IL57005A (en) 1983-11-30
MX5898E (es) 1984-08-22
PL118404B1 (en) 1981-10-31
CA1138453A (en) 1982-12-28
ATA267079A (de) 1983-04-15
YU84179A (en) 1983-04-30
RO76810A (ro) 1981-05-30
IT1118476B (it) 1986-03-03
MY8500703A (en) 1985-12-31
AT372956B (de) 1983-12-12
US4523015A (en) 1985-06-11
ES479469A1 (es) 1979-07-16
AU527202B2 (en) 1983-02-24
CS210684B2 (en) 1982-01-29
SU944504A3 (ru) 1982-07-15
IE790364L (en) 1979-10-11
CY1194A (en) 1983-12-31
KR820002136B1 (ko) 1982-11-15
PH16240A (en) 1983-08-11
SU906376A3 (ru) 1982-02-15
IT7967751A0 (it) 1979-04-09
IE48080B1 (en) 1984-09-19
GR66986B (cs) 1981-05-15
EP0004793A3 (en) 1979-11-28
DK147379A (da) 1979-10-12
JPS54138580A (en) 1979-10-27

Similar Documents

Publication Publication Date Title
CA1147335A (en) Process for preparing pyrimidones
NO791225L (no) Fremgangsmaate for fremstilling av 2-aminopyrimidoner
NO120426B (cs)
NO141163B (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive pyrimidiner
CA1073458A (en) Pyrimidone derivatives
US4227000A (en) Intermediates in the process for making histamine antagonists
US4652650A (en) Pyridylaminoalkylamine intermediates
NO834778L (no) Fremgangsmaate for fremstilling av pyridinderivater for anvendelse som histamin h1-antagonister
KR880001473B1 (ko) 치환된 피리미디논의 제조방법
CA1133481A (en) Process for making histamine antagonists
JPH0447671B2 (cs)
JPS58118585A (ja) 抗潰瘍薬
EP0024873A1 (en) A process for preparing pyrimidones
Coppola et al. Pyrimidones. 2. Synthesis and reactions of 2‐chloropyrimidines
KR880001474B1 (ko) 치환된 피리미디논의 제조방법
US4477663A (en) Intermediates for preparing substituted pyrimidinones
US4675406A (en) Substituted pyrimidinones
US4620001A (en) Chemical methods and intermediates for preparing substituted pyrimidinones
US4569996A (en) Process for preparing substituted pyrimidinones
EP0017680A1 (en) Pyrimidone derivatives, process for preparing them and pharmaceutical compositions containing them
NO781587L (no) Benzylpyrimidiner og fremgangsmaate til fremstilling av disse